Filing Details
- Accession Number:
- 0001021561-20-000077
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-12-15 17:09:04
- Reporting Period:
- 2020-12-15
- Accepted Time:
- 2020-12-15 17:09:04
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1021561 | Nu Skin Enterprises Inc. | NUS | Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122) | 870565309 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1652984 | S Ryan Napierski | C/O Nu Skin Enterprises, Inc. 75 West Center Street Provo UT 84601 | President | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Disposition | 2020-12-07 | 3,000 | $0.00 | 78,500 | No | 5 | G | Direct | |
| Class A Common Stock | Acquisiton | 2020-12-15 | 7,000 | $30.63 | 85,500 | No | 4 | M | Direct | |
| Class A Common Stock | Disposition | 2020-12-15 | 7,000 | $50.97 | 78,500 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 5 | G | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Class A Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2020-12-15 | 7,000 | $0.00 | 7,000 | $30.63 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 77,800 | 2023-03-02 | No | 4 | M | Direct |
Footnotes
- Sale pursuant to a 10b5-1 plan adopted by the Reporting Person.
- The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $50.85 to $51.21, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission full information regarding the number of shares sold at each separate price within this range.
- Currently exercisable in full.
Billionaire Hedge Funds
